Synaptogenesis at the neuromuscular junction requires agrininduced stable localization of acetylcholine receptors (AChRs) at the endplate. The effects of agrin are transduced by the muscle-specific receptor tyrosine kinase (MuSK). This study provides evidence that Src-class protein tyrosine kinases mediate the effects of agrin-activated MuSK to regulate clustering and anchoring of AChRs in skeletal muscle. MuSK was complexed with both Src and Fyn in the C2 mouse muscle cell line. These associations were enhanced by agrin and by increasing protein tyrosine phosphorylation with pervanadate. Coupling between MuSK and the Src-class kinases in vivo appeared to be caused by a phosphotyrosine-SH2 domain interaction because binding of MuSK to the SH2 domains of Fyn and Src in vitro was specific, enhanced by phosphorylation, and dependent on MuSK autophosphorylation. In addition, Src and Fyn phosphorylated MuSK. AChR phosphorylation, stimulated by agrin or pervanadate, was inhibited by blocking Src-class kinases with PP1. Furthermore, agrin-induced clustering and cytoskeletal anchoring of AChRs was dependent on Src-family kinases. These data support the conclusion that Fyn and Src act downstream of MuSK to regulate the stable localization of AChRs at the neuromuscular endplate during agrin-induced synaptogenesis.
etal anchoring, and phosphorylation of AChRs (Godfrey et al., 1984; Wallace et al., 1991; Wallace, 1995; Gautam et al., 1996; Cohen et al., 1997; Jones et al., 1997; Meier et al., 1997; . Previous studies indicate that the receptor for agrin includes MuSK Glass et al., 1996) . For example, MuSK-deficient myotubes fail to cluster AChRs in response to agrin . Rapsyn is a cytoskeletal, peripheral membrane protein crucial for AChR clustering and anchoring at the postsynaptic endplate (Barrantes et al., 1980; Burden et al., 1983; Walker et al., 1984; Froehner et al., 1990; Phillips et al., 1993; Gautam et al., 1995) . In rapsyn minus myotubes, agrin activates MuSK but does not induce phosphorylation or clustering of AChRs, indicating that rapsyn transduces the action of agrin-activated MuSK (Gautam et al., 1995; Apel et al., 1997) . Although insights into the mechanism for synaptogenesis at the NMJ have been gained, the exact relationships among agrin, MuSK, and rapsyn remain to be determined.
Protein tyrosine phosphorylation is important for AChR clustering and cytoskeletal anchoring (Meier et al., 1995; Wallace, 1995; Ferns et al., 1996; Fuhrer et al., 1997; Swope et al., 1999) . It has been suggested that a kinase downstream of MuSK directly phosphorylates AChRs Fuhrer et al., 1997) . Src-class kinases represent the predominant protein tyrosine kinase activity in AChR-enriched postsynaptic membranes (Swope and Huganir, 1993) . Src-family kinases complex with the AChR and phosphorylate the receptor in vitro Huganir, 1993, 1994; Fuhrer and Hall, 1996) . The functional significance of AChR phosphorylation by Src-class kinases may be in anchoring the receptor to the cytoskeleton. For example, Src-family kinases are complexed with rapsyn, and activation of Src-class kinases by rapsyn in heterologous cells results in AChR phosphorylation and cytoskeletal binding (Mohamed and Swope, 1999) . The goal of the present study was to further clarify the signal transduction QT-6 transfection, 2 g each of inactive MuSK[K686R] , MuSK , rapsyn, Fyn, Src, Btk, or pBK-C M V plasmid constructs was used per 60 mm dish, and pBK-C M V was added, if necessary, to bring the total amount of plasmid DNA to 12 g per dish. For transfection of C OS-7 cells, 30 g of agrin 4,8 was used per 100 mm dish. In each case, transfection efficiency was typically Ն50%, as determined by the Green Lantern vector (Life Technologies). For transfection of C2 cells, 2 g dominant negative Src or empty plasmid was mixed with 3 l of FuGene (Roche) and 100 l of serum-free DM EM and pipetted directly onto 35 mm wells containing 60 -80% confluent myoblasts. After 1-2 min, 2 ml of DM was added, and the cells were returned to the incubator. After 48 hr, the medium was replaced with fresh DM, and the cells were treated with or without agrin 10 hr later. Transfection efficiency was typically ϳ20%, as determined by the Green Lantern vector.
Phosphor ylation of MuSK in QT-6 cells. Transfected QT-6 cells expressing MuSK or MuSK[K686R] were solubilized in 2% SDS, 50 mM Tris, pH 7.4, 150 mM NaC l, 2 mM EDTA, 4 mM EGTA, 2 mM sodium orthovanadate (SDS-lysis buffer) for 10 min at 22°C. The lysates were diluted to a final concentration of 0.4% SDS and 2% Triton X-100 at 1 mg /ml protein. Lysates were sonicated for 30 sec on ice and spun at 225,000 ϫ g for 10 min at 4°C. Solubilized proteins after centrif ugation were immunoprecipitated with the polyclonal anti-myc antibody (JH2235).
Immunoprecipitates were analyzed by Western blotting using a mixture of anti-phosphotyrosine monoclonal antibodies 4G10 and PY99.
Phosphor ylation of MuSK and AChR in C2 myotubes. C2 myotubes were preincubated for 1 hr in DM EM supplemented with 0.1% horse serum followed by pretreatment with or without 10 or 20 M PP1 for 1 hr. Myotubes were then incubated with or without 100 pM agrin or 30 M pervanadate. Treated myotubes were rinsed twice with ice-cold PBS and solubilized on ice for 10 min using 50 mM Tris, pH 7.4, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaC l, 2 mM EDTA, 4 mM EGTA, and 1 mM sodium vanadate (RI PA buffer) supplemented with the protease inhibitors, 0.1 mM phenylmethylsulfonylfluoride, 10 g /ml pepstatin, 10 g /ml chymostatin, 10 mg /l antipain, and 10 U/l Trasylol. Lysates were centrif uged at 225,000 ϫ g for 10 min, and the supernatants were immunoprecipitated with antibodies specific for MuSK (GW002) or AChR (88b). Phosphorylation of MuSK was analyzed by Western blotting with a mixture of the anti-phosphotyrosine antibodies, 4G10 and PY99. Phosphorylation of AChR was detected with a mixture of the phosphorylation state-specific anti-AChR ␤ subunit, JH1360, and antiAChR ␦ subunit, JH1358. AChR blots were stripped and reprobed with AChR ␤ subunit mAb 148.
Binding of MuSK to SH2 f usion proteins. SH2 domain f usion proteins were prepared as described previously (Swope and Huganir, 1994) . In brief, the cDNAs for SH2 domains from Src-class kinases and Grb2 were inserted into a bacterial expression vector containing the sequence for glutathione S-transferase (GST). The SH2-GST f usion protein was grown in BL21 bacteria and purified on glutathione agarose (Sigma). The f usion protein still bound to the agarose was subsequently used as an affinity reagent. Transfected QT-6 cells expressing MuSK or MuSK[K686R] were solubilized in SDS-lysis buffer for 10 min at 22°C. The lysates were diluted to a final concentration of 0.4% SDS plus 2% Triton X-100, sonicated for 30 sec on ice, and spun at 225,000 ϫ g for 10 min at 4°C. Solubilized proteins, after centrif ugation, were incubated with the SH2 domain f usion protein affinity resin for 2 hr, and nonspecific proteins were washed away as described previously (Swope and Huganir, 1994) . Binding of MuSK was detected by Western analysis using anti-myc mouse monoclonal 9E10.
Immunoprecipitation and coimmunoprecipitation. C2 myotubes were rinsed with ice-cold PBS and solubilized for 15 min either in 50 mM Tris, pH 7.4, 150 mM NaC l, 4 mM EGTA, 4 mM EDTA, 1% Triton X-100, and 2 mM Na-orthovanadate (Triton lysis buffer) or in RI PA buffer supplemented with the protease inhibitors, 0.1 mM phenylmethylsulfonylfluoride, 10 g /ml pepstatin, 10 g /ml chymostatin, 10 mg /l antipain, and 10 U/l Trasylol. Lysates were centrif uged at 225,000 ϫ g for 10 min, and the supernatants were immunoprecipitated with antibodies specific for MuSK (a mixture of N19 and C19 or, alternatively, GW002), AChR (88b), Fyn (Fyn 15), or Src (Ab-1). Immunoprecipitates were analyzed for precipitated or coprecipitated proteins by immunoblotting using specific antibodies for MuSK (␣-MuSK-Z H), a mixture of the phosphorylation state-specific anti-AChR ␤ subunit (JH1360), and anti-AChR ␦ subunit (JH1358) antibodies, AChR ␤ subunit (mAb 148), Fyn (Fyn 3), Src (GD11), or Fyn and /or Src (Src2) .
Detergent e xtraction. C2 myotubes were preincubated with DM E-F12 (Sigma) supplemented with 1 mg /ml bovine serum albumin (BSA) (RIA Grade, Sigma) and pretreated with or without 10 -20 M PP1 followed by treatment with or without 100 pM agrin. Treated myotubes were rinsed twice with ice-cold PBS and extracted on ice with 10 mM H EPES, pH 7.4, 50 mM NaC l, 300 mM sucrose, 1 mM MgC l 2 , and 1 mM Na-orthovanadate (Prives buffer) (Prives et al., 1982) containing 0.5% Triton X-100 and the protease inhibitors 0.1 mM phenylmethylsulfonylfluoride, 10 g /ml pepstatin, 10 g /ml chymostatin, 10 mg /l antipain, and 10 U/l Trasylol. Treatment of cultured myotubes with Prives buffer rapidly extracts the plasma membrane and other membranous organelles but leaves the cytoskeleton intact (Prives et al., 1982) . After the desired time, the buffer was removed, and the cells were rinsed once with Prives buffer with 0.1% Triton X-100. Residual cytoskeletal proteins were solubilized and scraped from the dish with SDS-PAGE sample buffer, sonicated for 30 sec, and spun at 225,000 ϫ g for 10 min at 4°C. Solubilized cytoskeletal proteins were analyzed by SDS-PAGE and Western blotting using rat mAb 148, specific for the AChR ␤ subunit. For determining the effects of PP1 on the amount of AChRs, sister C2 cultures were treated and processed as above, except the Prives buffer contained no Triton X-100.
In vitro k inase assays. C2 myotubes were washed two times in ice-cold PBS and then solubilized in RI PA buffer plus the protease inhibitors 0.1 mM phenylmethylsulfonylfluoride, leupeptin 10 g /ml, and 10 U/l Trasylol. Lysates were spun at 225,000 ϫ g for 10 min at 4°C. Supernatants from each 60 mm dish of C2 myotubes were divided into three equal portions. One-third of each supernatant was used for immunoprecipitation of Fyn, using mAb Fyn 15, Src using mAb Ab-1, or MuSK using GW002. The immunocomplexes were immobilized using protein G-or protein A-Sepharose and washed three times in RI PA buffer, then twice in kinase reaction buffer without ATP. The immunoprecipitates were used in an in vitro phosphorylation reaction with 20 M ATP and 7.5 g acid-denatured enolase as described previously (Feder and Bishop, 1990) . The reactions were analyzed by Western blotting with a mixture of the anti-phosphotyrosine antibodies, 4G10 and PY99.
Treatments with PP1, agrin, or pervanadate. For biochemical analysis, C2 myotubes were preincubated in DM EM supplemented with 0.1% horse serum for 1 hr, then PP1, agrin, or pervanadate were added directly to the medium. For detergent extraction experiments, C2 myotubes were preincubated for 1 hr in DM E-F12 medium supplemented with 0.1% RIA grade BSA before agrin or PP1 treatments. Q-T6 cells were treated with pervanadate in growth medium containing Medium 199 (Life Technologies) supplemented with 1% DMSO, 5% FBS, 10% tryptose phosphate broth, and 1% penicillin-streptomycin. For microscopic analysis of clustering, myotubes in DM were treated overnight with agrin. The concentrations of agrin, pervanadate, and PP1 were 100 pM, 30 M, and 10 -20 M, respectively.
Immunoc ytochemistr y. Myotubes in DM were incubated at 37°C /8% CO 2 for 1 hr with 80 nM tetramethyl(rhodamine)-␣-bungarotoxin or Texas Red-␣-bungarotoxin (Molecular Probes, Eugene, OR). C ells at room temperature were washed with PBS, fixed for 15 min with 3% paraformaldehyde/4% sucrose, and then permeabilized with 0.1% Triton X-100 for 5 min. Myotubes expressing the dominant negative Src were identified by double labeling with the pan-Src kinase antibody, src2, followed by FI TC -goat-anti-rabbit secondary antibody (Molecular Probes). C ells were visualized by epifluorescence on a Nikon Eclipse TE300 inverted microscope using a 20ϫ objective. Images were captured with a Magnafire digital camera and software. C luster sizes were analyzed with Adobe Photoshop.
Immunoblotting. Proteins were resolved by SDS-PAGE and transferred to poly vinylidene difluoride (PV DF) membranes (Immobilon, Millipore, Bedford, M A) by electroblotting. The PV DF membranes were blocked in 5% nonfat milk in Tris-buffered saline (50 mM Tris, pH 7.4, 200 mM NaC l) containing 0.05% T ween 20. For phosphotyrosine immunoblotting, the PV DF membranes were blocked in 3-5% BSA. The dilutions for primary antibodies were as follows: anti-MuSK antibody (␣-MuSK-Z H), anti-phosphotyrosine 4G10, anti-phosphotyrosine PY99, and antiAChR ␤ subunit mAb 148, each at 1:1000; anti-Fyn (Fyn3) and Src2 (Pan-Src), each at 1:500; anti-myc mouse monoclonal (9E10), anti-active state Src kinase-specific rabbit antibody (GW001), and anti-Src mouse monoclonal (GD11), each at 1:200. Horseradish peroxidase-conjugated secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA) and were used at dilutions of 1:50,000. Horseradish peroxidase-bound signal was detected using an enhanced chemiluminescence (ECL) (Pierce, Rockford, IL) followed by exposure of BioMax MR-1 film (Eastman Kodak, Rochester, N Y) or, for greater sensitivity, HyperFilm ECL (Amersham, Arlington Heights, IL). For some experiments, blots were stripped by incubation at 55°C for 30 min in 62.5 mM Tris, pH 6.8, 2% SDS, and 100 mM ␤-mercaptoethanol and reanalyzed by Western blotting.
Agrin production. Medium from C OS-7 cells expressing a C -agrin 4,8 or transfected with empty plasmid pBK-C M V was collected and replaced each day for 2 d. The concentration of agrin in the collected medium was determined by Western blotting (Sugiyama et al., 1994) using agrinspecific polyclonal antiserum (JH1037) and standard purified agrin of known concentration provided by Dr. J. E. Sugiyama (N I N DS, N IH) .
Fusion protein production. SH2 domain f usion proteins derived from Fyn, Src, and Grb2 as well as backbone GST protein were prepared as described previously (Swope and Huganir, 1993) .
Pervanadate preparation. Sodium pervanadate was prepared as described previously (Meier et al., 1995 Fig. 1 A) . Normalization for all of the coimmunoprecipitations of Figures 1 and 2 Protein determinations. Protein concentrations were determined by the method of L owry using BSA as a standard (L owry et al., 1951) .
RESULTS

Association of Src-class kinases with MuSK
To test for a relationship between Src-class kinases and MuSK, complex formation between these two types of kinases was examined initially. C2 myotube proteins were solubilized under mild conditions of 1% Triton lysis buffer to maintain proteinprotein interactions and immunoprecipitated with MuSK-specific antibodies. When the precipitates were analyzed for Src by Western blotting, there was specific coimmunoprecipitation of Src with MuSK compared with empty beads (Fig. 1 A, lane 2 vs 4 ). In a similar manner, Fyn was specifically coimmunoprecipitated with MuSK as demonstrated with a Fyn-specific antibody in Western analysis of the anti-MuSK immunoprecipitates and control beads ( Fig. 1 B, lane 2 vs 4 ). Activation of other receptor tyrosine kinases, such as the PDGF receptor, results in binding of Src-class kinases (Claesson-Welsh, 1994) . In fact, the trkB receptor kinase, which is closely related to MuSK, binds Fyn (Iwasaki et al., 1998) . Therefore, whether activation of MuSK by agrin enhanced association of MuSK with Src and Fyn was tested. Treatment of C2 cells for 1 hr with agrin increased complex formation between MuSK and both Fyn and Src ( Fig. 1 A, B , lane 1 vs 2). The percentage of each kinase complexed with MuSK was determined by comparing the Src and Fyn signal in the MuSK immunoprecipitate with an aliquot of lysed cells. Densitometry scanning quantification, with normalization for recovery of MuSK, was performed to determine the percentage of Src and Fyn complexed with MuSK. In the absence of agrin, the percentage of total Src and Fyn precipitated with MuSK was 1.7 Ϯ 0.2 and 2.10 Ϯ 0.08%, respectively. After agrin treatment, the percentage of Src coimmunoprecipitated was increased to 3.26 Ϯ 0.09% over nontreated cells ( p Ͻ 0.05), whereas the percentage of Fyn was increased to 3.8 Ϯ 0.3% ( p Ͻ 0.025). For both kinases, an enhancement of association with MuSK in response to agrin occurred in every experiment. The average percentage increase in association of Fyn and Src with MuSK caused by agrin was 80 Ϯ 20 and 110 Ϯ 50%, respectively. These data indicated that Src and Fyn were in a complex with MuSK and that this association was stimulated by agrin.
The existence of this complex was further tested by the recip- These data provided strong evidence that in C2 myotubes, Fyn and Src were complexed with MuSK under control conditions and that association was stimulated further by agrin. Because Fyn, Src, and MuSK are all protein tyrosine kinases, the effect of increasing phosphorylation on complex formation was examined. Treatment of C2 cells with pervanadate, an inhibitor of protein tyrosine phosphatases (Huyer et al., 1997) , resulted in a dramatic increase in protein tyrosine phosphorylation, indicating constitutive phosphorylation and dephosphorylation in C2 myotubes (A. S. Mohamed and S. L. Swope, unpublished results). To examine the effect of phosphorylation on association of MuSK and Src-class kinases, myotubes were treated under control conditions or with pervanadate, and MuSK was immunoprecipitated from the lysates. Src-class kinase(s) was specifically coprecipitated with MuSK as demonstrated by analysis of the MuSK precipitates by Western blotting using a pan-Src-class kinase antibody ( In two experiments, inhibition of protein tyrosine dephosphorylation increased the coimmunoprecipitation of Srcclass kinases with MuSK from 1.35 Ϯ 0.03 to 2.8 Ϯ 0.1%, and in a third experiment the increase was from 3.8 to 7.3%. Thus, all three experiments showed an increase in complex formation between Src kinases and MuSK by pervanadate treatment, with an average increase of 117 Ϯ 6%. The reverse analysis was also performed. Fyn and Src were immunoprecipitated from control and pervanadate-treated myotubes, and the precipitates were analyzed for MuSK. Pervanadate treatment increased coimmunoprecipitation of MuSK with Fyn ( Fig. 2 Association between receptor kinases, such as the PDGF receptor, and Src-class kinases is mediated by a phosphotyrosine -SH2 domain interaction. Because association of MuSK and Src-class kinases was enhanced by increased tyrosine phosphorylation, it was predicted that MuSK might bind with the SH2 domains of Fyn and Src. To test this possibility, fusion protein affinity chromatography was used. SH2 domain-containing fusion Figure 1 . Effect of agrin on coimmunoprecipitation of MuSK with Fyn and Src. A, C2 myotubes were treated with 100 pM agrin (Agrin ϩ) or an equal volume of conditioned medium vehicle (Agrin Ϫ) for 1 hr. Myotubes were solubilized in lysis buffer and centrifuged, and supernatants representing 90% of a 100 mm plate were immunoprecipitated with a mixture of goat polyclonal anti-MuSK antibodies, N19 and C19 (MuSK ), or empty protein A-Sepharose (PAS). The immunoprecipitates and 100 g of lysate supernatant after centrifugation (Lys) were resolved by 8% SDS-PAGE and analyzed by Western blotting using anti-Src antibody GD11 (␣-Src). B, The blot from A was stripped and reanalyzed by Western blotting using anti-Fyn antibody Fyn3 (␣-Fyn). C, The blot from A was stripped and reanalyzed by Western blotting using anti-MuSK-ZH antibody (␣-MuSK ). D, C2 myotubes were treated with agrin or conditioned medium vehicle and solubilized as in A. The supernatants after centrifugation were immunoprecipitated with anti-Fyn antibody Fyn15 (Fyn), anti-Src antibody Ab-1 (Src), or empty protein G-Sepharose (PGS). The immunoprecipitates and 100 g of lysate supernatant after centrifugation (Lys) were resolved by 7% SDS-PAGE and analyzed by Western blotting using anti-MuSK-ZH antibody (␣-MuSK ). E, The blot from D was stripped and reanalyzed by Western blotting with anti-Src-family kinase antibody Src2 (␣-pan-Srcks). In A-E, an arrowhead indicates the position of Src, Fyn, MuSK, MuSK, and Src-class kinases, respectively. proteins derived from Fyn, Src, and Grb2 were incubated with myc-tagged MuSK solubilized from heterologous transfected QT-6 fibroblasts. MuSK bound to the Fyn and Src SH2 domain fusion proteins as detected by anti-myc Western analysis (Fig.  3A) . The binding was specific in that MuSK did not bind to backbone fusion protein or the Grb2 SH2 fusion protein. In addition, MuSK did not bind to the SH3 domains of Fyn or Src (J. R. Kraas and S. L. Swope, unpublished results). Because MuSK was solubilized under extremely stringent conditions of 2% SDS lysis buffer, which promotes dissociation of protein complexes, these data suggested that MuSK bound directly to the Fyn and Src SH2 domain fusion proteins. However, an indirect interaction cannot be ruled out.
The concentration-dependence for binding of MuSK to the Fyn and Src SH2 domains was analyzed. Increasing concentrations of Fyn and Src SH2 domain fusion proteins, 0.3-30 g, were incubated with solubilized myc-tagged MuSK. MuSK bound slightly better to the Src SH2 domain (Fig. 3B ). These data suggested that association of MuSK with Fyn and Src was mediated by binding of the Src-class kinases' SH2 domains to the receptor tyrosine kinase and that MuSK bound with a slightly higher affinity to Src.
Receptor tyrosine kinases bind Src-class kinases via phosphotyrosine motifs on the receptors. In vivo, these tyrosines are phosphorylated by ligand-induced dimerization and auto/ transphosphorylation of the receptor tyrosine kinases (ClaessonWelsh, 1994; Thomas and Brugge, 1997) . Whether the binding of MuSK to the SH2 domain fusion protein of Src-class kinases was dependent on MuSK transphosphorylation was tested using a catalytically inactive MuSK construct containing a lysine to arginine point mutation (MuSK[K686R]) (Gillespie et al., 1996 (Fig. 3C, lanes 11 and  12) . Treatment of the cells expressing wild-type MuSK with pervanadate to block dephosphorylation caused an increase in the binding of wild-type MuSK to the Src SH2 domain fusion protein (Fig. 3C, lane 1 vs 7 ) . However, after treatment with pervanadate, binding of MuSK[K686R] was still not detected (Fig. 3C, lane 2) . Analysis of the lysates demonstrated that the expression levels of wild type and MuSK[K686R] were unaffected by pervanadate (Fig. 3C, lanes 5 and 6 vs 11 and 12) . These data indicated that binding of the wild-type MuSK to the SH2 domain fusion protein was dependent on tyrosine phosphorylation of MuSK. In addition, the phosphorylation was attributable to autophosphorylation of MuSK because catalytically inactive MuSK was unable to bind to the SH2 domain fusion protein.
Phosphorylation of MuSK and the AChR by Src-class kinases
A mechanism for reciprocal regulation between receptor and Src-class kinases has been elucidated in other systems. Ligandactivated autophosphorylation of receptor tyrosine kinases results in binding of Src-class kinases via their SH2 domains. This binding leads to phosphorylation of the receptor kinase by Srcclass kinases and thus creates binding sites on the receptor for an additional SH2 domain containing enzymes and adapter proteins (Claesson-Welsh, 1994). As described above and by others, MuSK does autophosphorylate (Gillespie et al., 1996) . Whether MuSK could be a substrate for Src and Fyn was tested next. For this analysis, the myc-tagged MuSK[K686R] was coexpressed with Src and Fyn in a heterologous cell line. Because MuSK was not catalytically active, any MuSK phosphorylation could not be caused by autophosphorylation. In fact, when MuSK[K686R] was expressed alone and then immunoprecipitated with anti-myc antibody, no phosphorylation was observed, as demonstrated by phosphotyrosine Western blotting (Fig. 4 A, lane 7 ) ; however, when coexpressed with Src, MuSK[K686R] was phosphorylated (Fig. 4 A, lane 1) . Some random variability in the isolation of MuSK occurred (Fig. 4 B, lanes 1-8) ; however, changes in the amounts of MuSK precipitated could not account for the "all" or nothing phosphorylation of MuSK[K686R] in the presence or absence of Src, respectively (Fig. 4 A, B, lane 1 vs 7 ) . Isolation of MuSK was dependent on transfection with the MuSK[K686R] plasmid because MuSK could not be precipitated from control cells transfected with empty plasmid (Fig. 4 B, lane 10) . Thus, catalytically inactive MuSK could be phosphorylated upon coexpression with Src.
Phosphorylation of MuSK by Fyn was also tested. In this transfection system, the activity of expressed Fyn is low, but Fyn activity can be increased by rapsyn (Mohamed and Swope, 1999) . In fact, phosphorylation of MuSK via Fyn was observed only after coexpression of rapsyn (Fig. 4 A, lane 3 vs 4 ) . In two of three experiments, phosphorylation of MuSK by Src was also potentiated by rapsyn. We tested whether the phosphorylation of MuSK was specific for Src-family kinases. Btk, a non-receptor kinase distinct from but related to the Src-family, mediated little or no phosphorylation of MuSK, demonstrating the specificity of the effect of Src and Fyn (Fig. 4 A, lanes 5 and 6) . These data supported the idea that MuSK can be phosphorylated by Src and Fyn and in addition suggested that MuSK is a substrate for these kinases in muscle.
Whether Fyn and Src phosphorylate MuSK in muscle cells was examined pharmacologically. PP1 is a highly selective Src-class kinase inhibitor. Depending on the specific Src family kinase and the cell type examined, PP1 has ID 50 values of 10 -100 nM in vitro and 0.5-30 M in intact cells (Hanke et al., 1996; Liu et al., 1999 (Thomas and Brugge, 1997) . Thus, phosphorylation at this site can be used as a measure of activation. We developed an anti-Y 416 phosphorylation state-specific antibody, GW001, to examine the activity of Src-class kinases by Western blotting, as described in Materials and Methods. The ability of PP1 to inhibit Src and Fyn activities in C2 cells was analyzed using the anti-PY 416 Src antibodies. The Y 416 phosphorylation of Fyn and Src immunoprecipitated from control C2 myotubes was low (Fig. 5A, lanes 1 and 5) (Fig. 5A , bottom panel ). Upon normalization for the amount of kinase isolated, Fyn autophosphorylation/activity was found to be 75 Ϯ 7 and 90 Ϯ 2% with 10 and 20 M PP1, respectively. Src activity was inhibited by 60 Ϯ 10 and 60 Ϯ 10% with 10 and 20 M PP1, respectively. The higher sensitivity of Fyn to PP1, compared with Src, agreed with a previous report (Hanke et al., 1996) . These data demonstrated that as measured by autophosphorylation, PP1 blocked the activity of Fyn and Src in C2 myotubes.
To reveal constitutive phosphorylation of MuSK by Src-class kinases, pervanadate and PP1 were also used. C2 myotubes were treated with pervanadate, and endogenous MuSK phosphoryla- (Rap) . Replicate control cultures were transfected with rapsyn or empty vector ( pCMV ) alone. After 40 hr, the cells were solubilized with 2% SDS lysis buffer, diluted to 0.4% SDS/2% Triton X-100, and MuSK immunoprecipitated from lysate representing 90% of a 100 mm plate using an anti-myc antibody JH2235. Immunoprecipitates were resolved by 8% SDS-PAGE and analyzed by immunoblotting with ( A) antiphosphotyrosine antibodies 4G10 and PY99 (␣-PY ) and ( B) anti-myc antibody 9E10 (␣-myc).
tion was examined by immunoprecipitation and Western blotting. Tyrosine phosphorylation of MuSK was essentially undetectable in control cells, whereas pervanadate treatment resulted in a striking increase in MuSK phosphorylation (Fig. 5B, lane 1 vs 2) . Incubation of C2 cells with PP1 inhibited pervanadate-induced MuSK phosphorylation (Fig. 5B, lane 2 vs 3 and 4 ) . In each of three experiments, PP1 at 20 M was slightly more effective than at 10 M. Inhibition of pervanadate-induced MuSK phosphorylation by 10 and 20 M PP1 was 50 Ϯ 10 and 60 Ϯ 10%, respectively. Neither pervanadate nor PP1 affected MuSK expression (Fig. 5B, bottom panel ) . The effect of PP1 suggested that approximately half of the induced phosphorylation of MuSK was caused by Src-class kinases.
One of the major goals of this study was to determine whether Src-class kinases phosphorylate and regulate AChRs of skeletal muscle. Phosphorylation of the AChR by Src and Fyn was also tested pharmacologically. Once again, C2 cells were treated with or without pervanadate and PP1. AChRs were immunoprecipitated and tyrosine phosphorylation was examined using phosphorylation state-specific anti-␤ and anti-␦ subunit antibodies. AChR phosphorylation was low in control cells, whereas pervanadate dramatically increased receptor phosphorylation (Fig. 5C , lane 1 vs 2). When we corrected for recovery of AChRs (Fig. 5C , bottom panel ), a 22-to 26-fold increase in phosphorylation of the ␤ subunit and a 10-to 130-fold increase in phosphorylation of the ␦ subunit occurred. This phosphorylation appeared to be attributable, in part, to Src-class kinases, as demonstrated by inhibition with PP1 (Fig. 5C , lane 2 vs 3 and 4 ). Cells pretreated with 10 and 20 M PP1 showed a 60 Ϯ 7 and 70 Ϯ 10% inhibition of pervanadate-induced ␤ subunit phosphorylation, respectively. Inhibition of ␦ subunit phosphorylation was 54 Ϯ 4 and 72 Ϯ 7% by 10 and 20 M PP1, respectively. Therefore, phosphorylation of AChRs by Src-class kinases occurred in C2 cells. MuSK phosphorylation in C2 myotubes was inhibited by PP1 (Fig. 5B ). These data suggested that Src-class kinases phosphorylated MuSK in muscle cells. However, because MuSK autophosphorylates, the effect of PP1 on MuSK might have been to inhibit autophosphorylation. Whether PP1 could block MuSK kinase activity in vitro was used to further test the conclusion that MuSK was phosphorylated by Src kinases in C2 cells. C2 myotubes were treated with or without pervanadate, MuSK was immunoprecipitated, and MuSK activity was analyzed in vitro using enolase as a substrate (Fig. 6 A) . Phosphorylation of both MuSK and enolase was detected by anti-phosphotyrosine immunoblotting. In control cells, no phosphorylation of MuSK or enolase was observed (Fig.  6 A, top and bottom panels, lane 2) . Pervanadate treatment caused a striking increase in both MuSK and enolase phosphorylation (Fig. 6 A, top and bottom panels, lane 1) . Phosphorylation of enolase occurred in vitro because it was dependent on ATP in the reaction (Fig. 6 A, bottom panel, lane 3) . In contrast, MuSK phosphorylation was independent of ATP in the in vitro reaction, demonstrating that MuSK phosphorylation occurred in the intact myotubes (Fig. 6 A, top panel, lane 1 vs 3) . As expected, inclusion of 1 or 5 M PP1 in the in vitro reaction did not affect the in vivo phosphorylation of MuSK (Fig. 6 A, top panel, lane 1 vs 4 and 6 ). In addition, enolase phosphorylation by MuSK was not affected by 1 or 5 M PP1 added to the in vitro reaction (Fig. 6 A, bottom  panel, lane 1 vs 4 and 6 ) . The phosphorylation of enolase in the presence of 10 and 20 M PP1 was 96 Ϯ 4 and 104 Ϯ 5%, respectively, of the level in the absence of PP1. These data demonstrated that PP1 did not directly inhibit the enzymatic activity of MuSK.
In contrast, PP1 did block the enzymatic activity of Fyn and Src in vitro. Using the same paradigm, myotubes were treated with or without pervanadate, Fyn and Src were isolated, and in vitro phosphorylation of enolase in the presence or absence of PP1 was determined. Pervanadate treatment of the myotubes stimulated in vitro phosphorylation of enolase by both Fyn and Src (Fig. 6 B, top  panel, lane 1 vs 2 and lane 8 vs 9) . The phosphorylation of enolase by Fyn and Src occurred in vitro because it was dependent on ATP in the reaction (Fig. 6 B, lane 1 vs 3 and lane 8 vs 10) . Fynmediated phosphorylation of enolase was inhibited by PP1 (Fig.  6 B, lane 1 vs 4 and 6 ) . Fyn activity was inhibited in vitro by 69 Ϯ 5 and 96 Ϯ 4% with 1 and 5 M PP1, respectively. Similarly, Src activity was inhibited by 91 Ϯ 1 and 100 Ϯ 1% with 1 and 5 M PP1, respectively (Fig. 6 B, lane 8 vs 11 and 13) . These data Figure 5 . Effect of inhibiting Src-class kinases on pervanadate-induced MuSK and AChR phosphorylation in vivo. A, C2 myotubes were treated with 10 or 20 M PP1 or vehicle for 1 hr followed by treatment with (PV ϩ) or without (PV Ϫ) 30 M pervanadate for 10 min. Myotubes were solubilized in RIPA buffer and centrifuged, and supernatants representing 20% of a 60 mm dish were immunoprecipitated with Fyn antibody Fyn15 (Fyn) or Src antibody Ab-1 (Src). The immunoprecipitates were resolved by 8% SDS-PAGE and analyzed by Western blotting using phosphorylation state-specific anti-Src-class kinase antibody GW001 (␣-PY 416 ) (top panel ). The PY416 blot was stripped and reanalyzed by Western blotting using anti-Src-class kinase antibody Src2 ( pan Srcks) (bottom panel ). B, Supernatants representing 20% of a 60 mm dish as in A were immunoprecipitated with anti-MuSK antibody GW002 (MuSK ). The immunoprecipitates were resolved by 7% SDS-PAGE and analyzed by Western blotting using a mixture of anti-phosphotyrosine antibodies 4G10 and PY99 (␣-PY ) (top panel ). Supernatants representing 1% of a 60 mm dish were resolved by 7% SDS-PAGE and analyzed by Western blotting using anti-MuSK antibody ␣-MuSK-ZH (␣-MuSK ) (bottom panel ). C, Supernatants representing 20% of a 60 mm dish as in A were immunoprecipitated with anti-AChR antibody 88b (AChR). The immunoprecipitates were resolved by 8% SDS-PAGE and analyzed by Western blotting using a mixture of the phosphorylation state-specific anti-AChR ␤ subunit (JH1360) and anti-AChR ␦ subunit (JH1358) antibodies (␣-AChR-PY ) (top panel ). The top blot from C was stripped and reanalyzed by Western blotting using the AChR ␤ subunit antibody mAb 148 (␣-AChR) (bottom panel ). In A-C, an arrowhead indicates the position of Src-class kinases, MuSK, and AChR ␤ and ␦ subunits, respectively. demonstrated that the enzymatic activity of Src and Fyn kinases from C2 myotubes was inhibited by PP1, whereas the activity of MuSK was not. Furthermore, these data support the idea that phosphorylation of MuSK and the AChR in C2 myotubes was attributable to Src-class kinases (Fig. 5 B, C) .
Agrin activates MuSK and induces MuSK phosphorylation . Whether agrin-stimulated phosphorylation of MuSK was dependent on Src-class kinases was tested. For this experiment, C2 myotubes were treated with agrin, MuSK was immunoprecipitated, and phosphorylation was examined by Western blotting. Agrin induced MuSK phosphorylation (Fig. 7A,  lane 1 vs 2) . The effect of agrin on MuSK phosphorylation was reduced by PP1 (Fig. 7A, lane 2 vs 3 and 4 ) . At 10 and 20 M, PP1 blocked agrin-stimulated MuSK phosphorylation by 40 Ϯ 10 and 69 Ϯ 6%. These data argue that phosphorylation of MuSK upon agrin treatment was attributable, in part, to Src-class kinases.
Phosphorylation of the AChR in response to agrin does not occur in myotubes derived from a MuSK knock-out mouse . Thus, agrin-stimulated phosphorylation of the AChR is dependent on MuSK. Whether agrin-stimulated/ MuSK-mediated AChR phosphorylation was dependent on Srcfamily kinases was examined. C2 myotubes were treated with agrin, AChRs were isolated, and phosphorylation was analyzed by Western blotting using the phosphorylation state anti-␤ and anti-␦ subunit antibodies. Agrin induced AChR phosphorylation (Fig. 7B, lane 1 vs 2) . The agrin-stimulated phosphorylation of the AChR was inhibited by PP1 (Fig. 7B, lane 2 vs 3 and 4 ) . The AChR ␤ subunit phosphorylation was blocked by 51 Ϯ 7 and 69.5 Ϯ 0.7% with 10 and 20 M PP1, respectively. The ␦ subunit phosphorylation was blocked by 60 Ϯ 10 and 74 Ϯ 8% with 10 and 20 M PP1, respectively. These data indicated that agrin activated Src-class kinases, resulting in phosphorylation of the AChR in C2 myotubes.
Cytoskeletal anchoring of the AChR by Src-class kinases
Agrin stimulates AChR anchoring to the cytoskeleton in muscle cells (Wallace, 1992) . Anchoring of AChRs is thought to be regulated by tyrosine phosphorylation (Wallace, 1992; Mohamed and Swope, 1999) . Because Src-class kinases appeared to mediate the effect of agrin to stimulate AChR phosphorylation (Fig. 7B) , a role for these kinases to regulate receptor anchoring was tested. The levels of anchored AChRs were determined by examining the resistance of the receptors to extraction with 0.5% Triton X-100, an approach previously demonstrated to be useful for analyzing interaction of AChRs with the cytoskeleton (Prives et al., 1982) . For this experiment, myotubes were treated with agrin, agrin plus PP1, or vehicle. The cells were then extracted with 0.5% Triton Figure 6 . Effect of inhibiting Src-class kinases on Fyn, Src, and MuSK kinase activities in vitro. A, C2 myotubes were treated with pervanadate at 30 M (PV ϩ) or vehicle (PV Ϫ) for 30 min. Myotubes were solubilized in RIPA buffer and centrifuged, and supernatants representing 30% of a 60 mm dish were immunoprecipitated with anti-MuSK antibody GW002 (MuSK ). The kinase activity of immunoprecipitated MuSK was determined with an in vitro kinase assay using enolase as a substrate in the presence of 1 or 5 M PP1 (PP1 ϩ) or vehicle (PP1 Ϫ) and the presence (ATP ϩ) or absence (ATP Ϫ) of ATP. For examining MuSK phosphorylation, kinase reactions were resolved by 7% SDS-PAGE and analyzed by Western blotting using anti-phosphotyrosine antibodies 4G10 and PY99 (␣-PY ) (top panel ). Enolase was resolved by 8% SDS-PAGE and analyzed by Western blotting using anti-phosphotyrosine antibodies 4G10 and PY99 (␣-PY ) (bottom panel ). Arrowheads indicate the positions of MuSK (MuSK ) and enolase (ENO). B, Supernatants from A representing 30% of a 60 mm dish were immunoprecipitated with anti-Fyn antibody Fyn 15 (Fyn) or anti-Src antibody Ab-1 (Src). The kinase activities of immunoprecipitated Fyn and Src were determined with an in vitro kinase assay using enolase as substrate as described in A. Enolase and Src-class kinases were resolved by 8% SDS-PAGE and analyzed by Western blotting using anti-phosphotyrosine antibodies 4G10 and PY99 (␣-PY ) (top panel ). The blots were stripped and reanalyzed by Western blotting using the pan-Src kinase antibody Src2 ( pan-Srcks) (bottom panel ). Arrowheads indicate the positions of enolase (ENO) and Src-class kinases (SrcKs). X-100 over a time course of 0 -20 min. The detergent-resistant cytoskeletal material remaining on the plate was eluted with SDS-PAGE sample buffer and analyzed for AChRs by Western blotting. With no extraction, the levels of total AChRs in the myotubes were similar for all treatments (Fig. 8 A, B, lanes 1-3) . Thus, neither agrin nor PP1 affected the total amount of receptor. After 5 min of Triton X-100 extraction, little AChR was nonextractable in the control cells (Fig. 8 A, lane 6 ) . Thus, most of the AChRs were soluble and not linked to the cytoskeleton in control cells. However, after agrin treatment, the level of nonextractable AChRs was increased, reflecting agrin-induced cytoskeletal anchoring (Fig. 8 A, lane 4 vs 6 ). In addition, PP1 partially reversed the action of agrin (Fig. 8 A, lane 4 vs 5) . The effect of PP1 could not be explained by an enhanced loss of cells (Fig. 8 B) . The same effects of agrin and PP1 were seen at 10 min of Triton X-100 extraction. As expected, most AChRs in control cells were solubilized by 10 min of extraction with Triton X-100 (Fig. 8 A, lane  9) . In cells treated with agrin, a pool of AChRs continued to be resistant to 10 min of detergent extraction (Fig. 8 A, lane 7 ) . The pool of receptors resistant to 10 min of extraction was smaller in cells treated with PP1 (Fig. 8 A, lane 8) . The same trend was observed with 20 min of extraction (Fig. 8 A, lanes 11-12) . The data in Figure 8C show the reproducibility of this effect. In four experiments, at all time points of Triton X-100 extraction, the levels of AChRs in the nonextractable fraction were enhanced by agrin, and the effect of agrin was significantly reversed by PP1 (Fig. 8C) . These data indicated that Src-class kinases mediate at least part of the effect of agrin to induce cytoskeletal anchoring of the AChR in muscle cells. Furthermore, these results support the importance of Src-class kinases in the stabilization of AChRs at the endplate during formation of the NMJ.
Maturation of AChR clustering by Src-class kinases
Whether the effect of agrin to induce AChR clustering was mediated by Src-class kinases was also examined. Two approaches were used: inhibition of Src kinases with PP1 or expression of a dominant negative Src. C2 myotubes were treated with agrin in the presence or absence of PP1, and AChR clustering was analyzed using tetramethyl(rhodamine)-␣-bungarotoxin or Texas Red-␣-bungarotoxin labeling and epifluorescence microscopy. Agrin-induced AChR clustering was still apparent in the presence of PP1 (Fig. 9, A vs B) . However, the size of receptor aggregates was altered by inhibition of Src-class kinases. The size distribution of receptor clusters was analyzed by binning into categories of Ͻ15 m, 15-25 m, and Ͼ25 m (Fig. 9 E, ϩPP1 and ϪPP1). The most obvious effect was a loss of large clusters and a dramatic shifting of clusters to sizes Ͻ15 m. The percentage of clusters Ͼ25 m in agrin-treated cultures was 57 Ϯ 3%, n ϭ 5, whereas after inhibition of Src-class kinases the number was reduced to 4.0 Ϯ 0.1%, n ϭ 5 (Fig. 9E, ϪPP1 vs ϩPP1 clear  bars) . Conversely, the percentage of clusters Ͻ15 m was 13 Ϯ 3% in control cells and 86 Ϯ 6%, n ϭ 5, in PP1-treated cells (Fig.  9 E, ϪPP1 vs ϩPP1, hatched bars) . These data indicated that inhibition of Src-class kinases with PP1 blocked the formation of large AChR clusters in response to agrin.
The role of Src-class kinases in the maturation of large AChR clusters was corroborated using a dominant negative approach. C2 cells were transfected to express a dominant negative Src and treated with agrin, and AChR clustering was analyzed. Cells expressing the dominant negative Src were identified by staining with a pan-Src kinase antibody, src2, whereas AChRs were identified with Texas Red-␣-bungarotoxin. Again, agrin-induced clustering occurred in cells expressing the dominant negative kinase; however, compared with control cultures transfected with empty plasmid, the size of receptor clusters was reduced by expression of dominant negative Src (Fig. 9, C vs D) . In contrast, expression of GFP did not affect AChR clustering (data not shown). For control cells, 37 Ϯ 2% of the clusters were 15-25 m and 33 Ϯ 3% were Ͼ25 m, whereas 31 Ϯ 4% of the clusters were Ͻ15 m (see Fig. 9 E, pBK ) . In contrast, in the cells expressing the dominant negative Src, 91 Ϯ 2% of the clusters were Ͻ15 m, whereas only 3 Ϯ 1% were Ͼ25 m (Fig. 9 E, DN Src) . These results provide strong evidence that Src-class kinases are critical for maturation of AChR clustering. Figure 8 . Effect of inhibiting Src-class kinases on agrin-induced AChR cytoskeletal anchoring. A, C2 myotubes were treated with 20 M PP1 (PP1 ϩ) or DMSO vehicle (PP1 Ϫ) for 1 hr followed by treatment with 100 pM agrin (Agrin ϩ) or conditioned medium vehicle (Agrin Ϫ) for 1 hr as indicated. Treated myotubes were extracted with Prives buffer containing 0.5% Triton X-100 for the indicated times and rinsed once with Prives buffer containing 0.1% Triton X-100. The proteins remaining on the dish were extracted using SDS-PAGE sample buffer, sonicated, and centrifuged. Aliquots of the SDS-extracted proteins representing 10% of a 35 mm dish were resolved by 8% SDS-PAGE and analyzed by Western blotting using anti-AChR ␤ subunit antibody mAb 148. B, Sister C2 cultures were treated with or without agrin, with or without PP1 as in A, and treated with Prives buffer without Triton X-100. Dishes were rinsed once with Prives buffer without Triton X-100. The proteins on the dish were extracted using SDS-PAGE sample buffer, sonicated, and centrifuged. SDS-extracted proteins representing 10% of 35 mm dishes were resolved by 8% SDS-PAGE and analyzed by Western blotting using anti-AChR ␤ subunit antibody mAb 148. C, Four independent experiments as in A were analyzed. C2 myotubes were treated with agrin (ࡗ), agrin ϩ 20 M PP1 (f), or vehicle control (OE). The data were quantified by densitometric scanning and represent the mean Ϯ SEM of the percentage of the total level of AChRs that remained on the dishes after 0.5% Triton X-100 extraction. In A and B, arrowheads indicate the position of the AChR ␤ subunit.
DISCUSSION
It has been predicted that a protein tyrosine kinase downstream of MuSK directly phosphorylates the AChR (Burden, 1998; Sanes et al., 1998; Fuhrer et al., 1999; Sanes and Lichtman, 1999) . In this study, MuSK was found to be complexed with the Src-class kinases Fyn and Src in the C2 mouse muscle cell line. These associations were enhanced by agrin and by increasing protein tyrosine phosphorylation. MuSK bound specifically to the SH2 domains of Fyn and Src, and this in vitro binding was dependent on autophosphorylation of MuSK. In addition, Fyn and Src phosphorylated MuSK in transfected cells. A highly selective inhibitor of Src-family kinases, PP1, blocked the enzymatic activity of Fyn and Src from C2 myotubes but did not affect the kinase activity of MuSK. With use of PP1, phosphorylation of MuSK and the AChR was demonstrated to be, in part, via Src-class kinases. In addition, Src-family kinases mediated agrin-induced anchoring of AChRs as well as maturation of AChR clustering. These data establish a structural and functional relationship for MuSK with Src and Fyn and provide evidence that Src-class kinases mediate the effects of agrin on the AChR.
Role of AChR phosphorylation in clustering and anchoring
The diffusion trap model proposes that after contact of the motor neuron with skeletal muscle, a "sticky zone" is created at the contact site where mobile AChRs become trapped (Edwards and Frisch, 1976) . In support of this theory, nonsynaptic AChRs are able to migrate freely, whereas clustered receptors are less mobile in the membrane (Young and Poo, 1983; Podleski and Salpeter, 1988; Meier et al., 1995) . Accumulation of AChRs at the nervemuscle contact site is due to migration of receptors to the developing endplate (Anderson and Cohen, 1977) . Furthermore, Figure 9 . Effect of inhibiting Src-class kinases on agrin-induced AChR clustering. A, B, C2 myotubes were treated with 20 M PP1 ( A) or DMSO vehicle ( B) for 1 hr followed by treatment with 100 pM agrin for 12 hr in the continued presence or absence of PP1. C, D, C2 myotubes were transfected with the dominant negative Src ( C) or empty plasmid ( D). After 55-60 hr, cells were treated for 12 hr with 100 pM agrin. For A-D, AChR clusters were visualized with Texas Red ␣-bungarotoxin, whereas for C and D, expression of the dominant negative Src was visualized by src2 staining, as described in Material and Methods. Scale bar, 20 m. E, Cluster sizes were analyzed and binned into three categories: Ͻ15, 15-25, and Ͼ25 m. The data represent the mean Ϯ SEM, n ϭ 5 experiments, for the effect of PP1 and n ϭ 3 experiments for the effect of dominant negative Src. For agrin Ϫ PP1, agrin ϩ PP1, agrin on pBK-CMV-transfected cells, and agrin on dominant negative Src-transfected cells, a total of 523, 518, 673, and 417 clusters, respectively, were analyzed. Note: The change in the receptor size distribution between the control transfected cells and the DMSO control for the PP1 experiment derives from the fact that low concentrations of DMSO appeared to promote agrin-induced clustering. mathematical modeling demonstrates that free diffusion of AChRs is fast enough to account for receptor accumulation at the endplate during synapse formation (Edwards and Frisch, 1976; Chao et al., 1981; Young and Poo, 1983; Kuromi et al., 1985) . Thus, trapping of receptors at the endplate is critical for synaptogenesis at the NMJ. The data presented here indicate that local activation of Src-class kinases may be a mechanism to create a sticky zone at the developing endplate.
Several lines of evidence support AChR tyrosine phosphorylation as a mechanism for receptor aggregation and stabilization within the cytoskeleton. Innervation induces AChR clustering and anchoring as well as receptor phosphorylation (Hall and Sanes, 1993; Qu and Huganir, 1994) . Agrin also induces AChR phosphorylation and clustering (Godfrey et al., 1984; Wallace et al., 1991) . Receptor phosphorylation in response to agrin precedes clustering, consistent with the idea that phosphorylation causes clustering (Wallace, 1992) . Conditions that induce AChR phosphorylation, such as agrin treatment, cotransfection with Src-class kinases, and pervanadate treatment, also stimulate receptor anchoring (Wallace, 1992; Meier et al., 1995; Wallace, 1995; Mohamed and Swope, 1999) . Furthermore, phosphorylation and anchoring of the AChR always occur with the same time course, suggesting a close functional relationship (Wallace, 1992 (Wallace, , 1995 . In addition, phosphorylated AChRs are more slowly extracted and hence are more tightly associated with the cytoskeleton than nonphosphorylated receptors (Meier et al., 1995) . Conversely, protein tyrosine kinase inhibitors block AChR phosphorylation, clustering, and anchoring (Figs. 8, 9 ) (Wallace, 1994; Ferns et al., 1996; Mohamed and Swope, 1999) . Of significance, a mutant AChR ␤ subunit lacking the tyrosine phosphorylation site assembles with endogenous AChR subunits of a muscle cell line, producing a receptor that forms only half the normal number of agrin-induced clusters. Furthermore, mutation of the ␤ subunit abolishes agrin-induced cytoskeletal anchoring of AChRs (Borges and Ferns, 2001) . Thus, tyrosine phosphorylation of the AChR ␤ subunit can regulate anchoring and clustering of AChRs. The results reported here reinforce this conclusion and support Src-class kinases in mediating agrin-induced phosphorylation of AChRs.
Cytoskeletal anchoring of AChRs appears to be reversible, involving two dynamic processes: actin polymerization and binding of AChRs to the cytoskeleton. Formation of clusters is associated with local actin polymerization. Furthermore, the newly formed clusters are sites for continued actin assembly. In fact, the force generated by actin polymerization is sufficient to move AChR clusters within the membrane (Dai et al., 2000) . AChR anchoring is also dynamic via reversible binding with the cytoskeleton. AChRs appears to exist in either a nonphosphorylated and mobile state or a phosphorylated and anchored state (Meier et al., 1995) . Two pieces of evidence indicate that these two forms of the receptor must exist in a dynamic equilibrium. First, AChR phosphorylation and cytoskeletal anchoring in response to agrin occur before clustering (Wallace, 1992) . Second, shifting the equilibrium far into the phosphorylated-anchored form of the AChR, using either pervanadate or viral Src, blocks receptor clustering, indicating that phosphorylated receptors are immobilized before they can aggregate (Anthony et al., 1984; Meier et al., 1995; Wallace, 1995) . Therefore, cytoskeletal polymerization and attachment of AChRs to the cytoskeleton must be dynamically regulated for proper postsynaptic localization of receptors. The results presented here suggest that reversible phosphorylation of AChRs via Src-class kinases may provide a dynamic mechanism for regulating receptor anchoring.
Role of additional phosphoproteins in synaptogenesis
The endplate consists of a complex matrix of proteins (Sanes and Lichtman, 1999) . Tyrosine phosphorylation is necessary for synaptogenesis at the NMJ; however, it is not known whether the AChR is the only important substrate. Several components of the postsynaptic complex, in addition to AChRs, are tyrosine phosphorylated. These proteins include rapsyn as well as ␣-dystrobrevin-1 and syntrophin of the dystrophin glycoprotein complex (Wagner et al., 1993; Wagner and Huganir, 1994; Qu et al., 1996; Balasubramanian and Huganir, 1999; Mohamed and Swope, 1999) . Phosphorylation of these proteins may also be important for promoting the cytoskeletal anchoring or proteinprotein interactions necessary for synaptogenesis. Both rapsyn and ␣-dystrobrevin are crucial for normal synaptogenesis at the NMJ; however, the structures of the NMJs in rapsyn and ␣-dystrobrevin knock-out mice are different. In rapsyn Ϫ / Ϫ myofibers, AChR clustering is completely absent in vivo as well as in response to agrin in culture (Gautam et al., 1995) . Whether rapsyn phosphorylation regulates its critical role in synapse formation is an interesting question. In ␣-dystrobrevin Ϫ / Ϫ mice, Figure 10 . Hypothetical model for the role of Src-class protein tyrosine kinases in phosphorylation and cytoskeletal anchoring of AChRs at the NMJ AChRs are in a dynamic equilibrium between a dephosphorylated mobile state ( A) and a phosphorylated anchored state ( B). In the mobile state, AChRs are in a complex with MuSK, rapsyn, ␣-dystroglycan (␣DG), and Src-family kinases. As the mobile complex diffuses into the nascent endplate, where MuSK is activated by agrin, the autophosphorylation sites on MuSK bind the SH2 domains of Src-class kinases, resulting in their activation. Activated Src-class kinases subsequently phosphorylate the AChR ␤ and ␦ subunits. In addition, MuSK and rapsyn are also phosphorylated by Src-class kinases. AChR phosphorylation by Src-class kinases induces receptor anchoring to the actin cytoskeleton. Phosphorylation of rapsyn and/or ␣-dystrobrevin-1 (␣DB-1) by Src-class or other kinases may also be important for formation and maturation of the NMJ endplate.
